Torrent Pharma rises on plans to acquire Encore's derma business

16 Apr 2015 Evaluate

Torrent Pharmaceuticals is currently trading at Rs. 1308.85, up by 3.90 points or 0.30% from its previous closing of Rs. 1304.95 on the BSE.

The scrip opened at Rs. 1310.00 and has touched a high and low of Rs. 1324.80 and Rs. 1297.00 respectively. So far 4463 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1334.75 on 15-Apr-2015 and a 52 week low of Rs. 545.05 on 23-Apr-2014.

Last one week high and low of the scrip stood at Rs. 1334.75 and Rs. 1220.00 respectively. The current market cap of the company is Rs. 22182.56 crore.

The promoters holding in the company stood at 71.51% while Institutions and Non-Institutions held 19.41% and 9.08% respectively.

Torrent Pharmaceuticals, is in talks to acquire the dermatology business of Mumbai-headquartered Encore group. The acquisition value of the dermatology business is around Rs 350 crore.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3820.45 27.80 (0.73%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×